The DOI matches its Crossref record; 99 of the 102 references it cites were found in a registry or an index.
Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?
Open accessAbstract
The amount of data collected and managed in (bio)medicine is ever-increasing. Thus, there is a need to rapidly and efficiently collect, analyze, and characterize all this information. Artificial intelligence (AI), with an emphasis on deep learning, holds great promise in this area and is already being successfully applied to basic research, diagnosis, drug discovery, and clinical trials. Rare diseases (RDs), which are severely underrepresented in basic and clinical research, can particularly benefit from AI technologies. Of the more than 7000 RDs described worldwide, only 5% have a treatment. The ability of AI technologies to integrate and analyze data from different sources (e.g., multi-omics, patient registries, and so on) can be used to overcome RDs’ challenges (e.g., low diagnostic rates, reduced number of patients, geographical dispersion, and so on). Ultimately, RDs’ AI-mediated knowledge could significantly boost therapy development. Presently, there are AI approaches being used in RDs and this review aims to collect and summarize these advances. A section dedicated to congenital disorders of glycosylation (CDG), a particular group of orphan RDs that can serve as a potential study model for other common diseases and RDs, has also been included.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Surveys show that patient satisfaction, provider training, research and quality improvement activities vary among medical centers (739,740);”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [739]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450
Biopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080
Predicting splicing from primary sequence with deep learning
Jaganathan, K., Kyriazopoulou Panagiotopoulou, S., McRae, J. F., Darbandi, S. F., Knowles, D., Li, Y. I., Kosmicki, J. A., Arbelaez, J., Cui, W., Schwartz, G. B., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.015 · Cited by 2,853
Identifying facial phenotypes of genetic disorders using deep learning
Gurovich, Y., Hanani, Y., Bar, O., Nadav, G., Fleischer, N., Gelbman, D., Basel-Salmon, L., Krawitz, P. M., Kamphausen, S. B., Zenker, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0279-0 · Cited by 739
Identifying Mendelian disease genes with the Variant Effect Scoring Tool
Carter, H. K., Douville, C. B., Stenson, P. D., Cooper, D. N., & Karchin, R. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s3-s3 · Cited by 593
Predicting the clinical impact of human mutation with deep neural networks
Sundaram, L., Gao, H., Padigepati, S. R., McRae, J. F., Li, Y., Kosmicki, J. A., Fritzilas, N., Hakenberg, J., Dutta, A., Shon, J. C., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0167-z · Cited by 505
Typical and atypical pathology in primary progressive aphasia variants
Spinelli, E. G., Mandelli, M. L., Miller, Z. A., Santos‐Santos, M. A., Wilson, S. M., Agosta, F., Grinberg, L. T., Huang, E. J., Trojanowski, J. Q., Meyer, M., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24885 · Cited by 409
AI in Health: State of the Art, Challenges, and Future Directions
Wang, F., & Preininger, A. (2019) · Yearbook of Medical Informatics · doi:10.1055/s-0039-1677908 · Cited by 398
Efficient Deep Network Architectures for Fast Chest X-Ray Tuberculosis Screening and Visualization
Pasa, F., Golkov, V., Pfeiffer, F., Cremers, D., & Pfeiffer, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-42557-4 · Cited by 372
ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants
Alirezaie, N., Kernohan, K. D., Hartley, T., Majewski, J., & Hocking, T. D. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.08.005 · Cited by 271
Congenital disorders of glycosylation (CDG): Quo vadis?
Péanne, R., de Lonlay, P., Foulquier, F., Kornak, U., Lefeber, D. J., Morava, É., Pérez, B., Séta, N., Thiel, C., SCHAFTINGEN, E. V., et al. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.10.012 · Cited by 265
Prediction of glycosylation sites using random forests
Hamby, S. E., & Hirst, J. D. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-500 · Cited by 236
Perspectives on Glycosylation and Its Congenital Disorders
Ng, B. G., & Freeze, H. H. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.03.002 · Cited by 232
The Application of Unsupervised Clustering Methods to Alzheimer’s Disease
Alashwal, H., Halaby, M. E., Crouse, J. J., ABDALLA, A. S., & Moustafa, A. A. (2019) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2019.00031 · Cited by 220
Neurology of inherited glycosylation disorders
Freeze, H. H., Eklund, E. A., Ng, B. G., & Patterson, M. C. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70040-6 · Cited by 210
The Challenge of Rare Diseases
Stoller, J. K. (2018) · CHEST Journal · doi:10.1016/j.chest.2017.12.018 · Cited by 198
Genome-wide association identifies diverse causes of common variable immunodeficiency
Orange, J. S., Glessner, J., Resnick, E. S., Sullivan, K. E., Lucas, M., Ferry, B. L., Kim, C. E., Hou, C., Wang, F., Chiavacci, R. M., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.039 · Cited by 195
A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse
Garcelon, N., Neuraz, A., Salomon, R., Faour, H., Benoît, V., Delapalme, A., Münnich, A., Burgun, A., & Rance, B. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.02.019 · Cited by 182
Glycosylation site prediction using ensembles of Support Vector Machine classifiers
Caragea, C., Sinapov, J., Silvescu, A., Dobbs, D. L., & Honavar, V. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-438 · Cited by 171
Jaeken, J., & Péanne, R. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0050-6 · Cited by 170
Kaufmann, P., Pariser, A., & Austin, C. P. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0936-x · Cited by 169
Looking beyond the hype: applied AI and machine learning in translational medicine
Toh, T. S., Dondelinger, F., & Wang, D. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.027 · Cited by 159
Phen-Gen: combining phenotype and genotype to analyze rare disorders
Javed, A., Agrawal, S., & Ng, P. C. (2014) · Nature Methods · doi:10.1038/nmeth.3046 · Cited by 146
Lunceford, J. K., Davidian, M., & Tsiatis, A. A. (2002) · Biometrics · doi:10.1111/j.0006-341x.2002.00048.x · Cited by 145
Ronicke, S., Hirsch, M. C., Türk, E., Larionov, K., Tientcheu, D., & Wagner, A. D. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1040-6 · Cited by 134
Recommendations for the design of small population clinical trials
Day, S. J., Jonker, A. H., Lau, L. P. L., Hilgers, R.-D., Irony, I., Larsson, K., Roes, K. C. B., & Stallard, N. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0931-2 · Cited by 133
The challenge of CDG diagnosis
Francisco, R., Marques‐da‐Silva, D., Brasil, S., Pascoal, C., Ferreira, V. D. R., Morava, É., & Jaeken, J. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.11.003 · Cited by 132
Self-citationNestler-Parr, S., Korchagina, D., Toumi, M., Pashos, C. L., Blanchette, C., Molsen, E., Morel, T., Simoens, S., Kaló, Z., Gatermann, R., et al. (2018) · Value in Health · doi:10.1016/j.jval.2018.03.004 · Cited by 131
Taroni, J., Grayson, P. C., Hu, Q., Eddy, S. F., Kretzler, M., Merkel, P. A., & Greene, C. S. (2019) · Cell Systems · doi:10.1016/j.cels.2019.04.003 · Cited by 119
van IJzendoorn, D. G. P., Szuhai, K., Bruijn, I. H. B., Kostine, M., Kuijjer, M. L., & Bovée, J. V. M. G. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006826 · Cited by 111
Maintaining order: COG complex controls Golgi trafficking, processing, and sorting
Blackburn, J. B., D'Souza, Z. C., & Lupashin, V. V. (2019) · FEBS Letters · doi:10.1002/1873-3468.13570 · Cited by 110
Li, Q., Zhao, K., Bustamante, C. D., Ma, X., & Wong, W. H. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0439-8 · Cited by 106
Predicting disease-causing variant combinations
Papadimitriou, S., Gazzo, A. M., Versbraegen, N., Nachtegael, C., Aerts, J. A., Moreau, Y., Dooren, S. V., Nowé, A., Smits, G., & Lenaerts, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815601116 · Cited by 105
CDG Therapies: From Bench to Bedside
Brasil, S., Pascoal, C., Francisco, R., Marques‐da‐Silva, D., Andreotti, G., Videira, P. A., Morava, É., Jaeken, J., & Ferreira, V. D. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051304 · Cited by 104
Self-citationHoehndorf, R., Schofield, P. N., & Gkoutos, G. V. (2015) · Scientific Reports · doi:10.1038/srep10888 · Cited by 102
Xu, K., Yang, Z., Kang, P., Wang, Q., & Liu, W. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.04.002 · Cited by 101
Identification of deleterious synonymous variants in human genomes
Buske, O. J., Manickaraj, A. K., Mital, S. R., Ray, P. N., & Brudno, M. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt308 · Cited by 98
The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact
Lochmüller, H., Torrent-Farnell, J., Cam, Y. L., Jonker, A. H., Lau, L. P. L., Baynam, G. S., Kaufmann, P., Dawkins, H. J. S., Lasko, P. F., Austin, C. P., et al. (2017) · European Journal of Human Genetics · doi:10.1038/s41431-017-0008-z · Cited by 93
Smith, K., Piccinini, F., Balassa, T., Koós, K., Danka, T., Azizpour, H., & Horváth, P. (2018) · Cell Systems · doi:10.1016/j.cels.2018.06.001 · Cited by 91
Recognition of the Cornelia de Lange syndrome phenotype with facial dysmorphology novel analysis
Basel‐Vanagaite, L., Wolf, L., Orin, M. J., Larizza, L., Gervasini, C., Krantz, I. D., & Deardoff, M. A. (2015) · Clinical Genetics · doi:10.1111/cge.12716 · Cited by 89
PEDIA: prioritization of exome data by image analysis
Hsieh, T., Mensah, M. A., Pantel, J. T., Aguilar, D., Bar, O., Bayat, A., Becerra-Solano, L. E., Bentzen, H. B., Biskup, S., Borisov, O., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0566-2 · Cited by 82
DeepPVP: phenotype-based prioritization of causative variants using deep learning
Boudellioua, I., Kulmanov, M., Schofield, P. N., Gkoutos, G. V., & Hoehndorf, R. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2633-8 · Cited by 79
Blasco, H., Patin, F., Descat, A., Garçon, G., Corcia, P., Gelé, P., Lenglet, T., Bede, P., Meininger, V., Devos, D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198116 · Cited by 74
Romero, R., Ramanathan, A., Yuen, T., Bhowmik, D., Mathew, M., Munshi, L. B., Javaid, S., Bloch, M., Lizneva, D., Rahimova, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818411116 · Cited by 74
Zarate, Y. A., Smith‐Hicks, C. L., Greene, C., Abbott, M., Siu, V. M., Calhoun, A. R. U. L., Pandya, A., Li, C., Sellars, E. A., Kaylor, J., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38630 · Cited by 71
Mavris, M., & Cam, Y. L. (2012) · Molecular Syndromology · doi:10.1159/000342758 · Cited by 66
Stacked ensemble combined with fuzzy matching for biomedical named entity recognition of diseases
Bhasuran, B., Murugesan, G., Abdulkadhar, S., & Natarajan, J. (2016) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2016.09.009 · Cited by 63
Garcelon, N., Neuraz, A., Benoît, V., Salomon, R., Kracker, S., Suárez, F., Bahi‐Buisson, N., Hadj-Rabia, S., Fischer, A., Münnich, A., et al. (2017) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.07.016 · Cited by 63
Rao, A., Saipradeep, V. G., Joseph, T., Kotte, S., Sivadasan, N., & Srinivasan, R. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0372-8 · Cited by 57
Izquierdo-Serra, M., Martínez‐Monseny, A. F., López, L., Carrillo-García, J., Edo, A., Ortigoza‐Escobar, J. D., García, Ó., Candela, R. C., Carrasco-Marina, M. L., Gutiérrez-Solana, L., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020619 · Cited by 56
Jurmeister, P. S., Schöler, A., Arnold, A., Klauschen, F., Lenze, D., Hummel, M., Schweizer, L., Bläker, H., Pfitzner, B. M., Mamlouk, S., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0207-y · Cited by 56
RDAD: A Machine Learning System to Support Phenotype-Based Rare Disease Diagnosis
Jia, J., Wang, R., An, Z., Guo, Y., Ni, X., & Shi, T. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00587 · Cited by 55
Marquardt, T., & Freeze, H. H. (2001) · Biological Chemistry · doi:10.1515/bc.2001.024 · Cited by 54
Rahman, M. S., Rahman, M. K., Kaykobad, M., & Rahman, M. S. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.11.003 · Cited by 53
CDG and immune response: From bedside to bench and back
Pascoal, C., Francisco, R., Ferro, T., Ferreira, V. D. R., Jaeken, J., & Videira, P. A. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12126 · Cited by 52
Self-citationCrow, R. A., Morehart, P. J., McDermott, M. P., Tawil, R., Martens, W. B., Herr, B. E., McColl, E., Wilkinson, J. S., Kirschner, J., King, W. M., et al. (2018) · Trials · doi:10.1186/s13063-018-2645-0 · Cited by 51
Shen, F., Liu, S., Wang, Y., Wen, A., Wang, L., & Liu, H. (2018) · JMIR Medical Informatics · doi:10.2196/11301 · Cited by 50
Marbach, F., Rustad, C. F., Rieß, A., Đukić, D., Hsieh, T., Jobani, I., Prescott, T., Bevot, A., Erger, F., Houge, G., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.02.021 · Cited by 50
Liehr, T., Acquarola, N., Pyle, K., St‐Pierre, S., Rinholm, M., Bar, O., Wilhelm, K., & Schreyer, I. (2017) · Clinical Genetics · doi:10.1111/cge.13087 · Cited by 48
In silico clinical trials for pediatric orphan diseases
Carlier, A., Vasilevich, A. S., Maréchal, M., de Boer, J., & Geris, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-20737-y · Cited by 45
Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer
Sernadela, P., González-Castro, L., Carta, C., van der Horst, E., Lopes, P. H. D. M. B., Kaliyaperumal, R., Thompson, M., Thompson, R., Queralt-Rosiñach, N., Martín, E. L., et al. (2017) · BioMed Research International · doi:10.1155/2017/8327980 · Cited by 45
Towards automated clinical coding
Catling, F. J. R., Spithourakis, G., & Riedel, S. (2018) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2018.09.021 · Cited by 42
Personalized Medicine: What’s in it for Rare Diseases?
Halfmann, S. S. G., Mählmann, L., Leyens, L., Reumann, M., & Brand, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67144-4_22 · Cited by 40
Citro, V., Cimmaruta, C., Monticelli, M., Riccio, G., Mele, B. H., Cubellis, M. V., & Andreotti, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082218 · Cited by 40
Mining Facebook Data of People with Rare Diseases: A Content-Based and Temporal Analysis
Subirats, L., Reguera, N., Hernández, A. M. B., Gómez‐Zúñiga, B., Minguillón, J., & Armayones, M. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15091877 · Cited by 37
Blackburn, J. B., Kudlyk, T. A., Pokrovskaya, I. D., & Lupashin, V. V. (2018) · Traffic · doi:10.1111/tra.12564 · Cited by 37
Deep Learning Model to Assess Cancer Risk on the Basis of a Breast MR Image Alone
Portnoi, T., Yala, A., Schuster, T., Barzilay, R., Dontchos, B. N., Lamb, L. R., & Lehman, C. D. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.18.20813 · Cited by 37
Validation of a new multiple osteochondromas classification through Switching Neural Networks
Mordenti, M., Ferrari, E., Pedrini, E., Fabbri, N., Campanacci, L., Muselli, M., & Sangiorgi, L. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35819 · Cited by 37
A Computable Phenotype Improves Cohort Ascertainment in a Pediatric Pulmonary Hypertension Registry
Geva, A., Gronsbell, J. L., Cai, T., Cai, T. A., Murphy, S. N., Lyons, J. C., Heinz, M. M., Natter, M. D., Patibandla, N., Bickel, J. P., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.05.037 · Cited by 36
Danter, W. R. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0983-3 · Cited by 35
The Application of Biomarkers in Clinical Trials for Motor Neuron Disease
Ganesalingam, J., & Bowser, R. P. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.71 · Cited by 33
Rare Disease Registries Classification and Characterization: A Data Mining Approach
Santoro, M. C., Coi, A., Paola, M. L. D., Bianucci, A. M., Gainotti, S., Mollo, E., Taruscio, D., Vittozzi, L., & Bianchi, F. (2015) · Public Health Genomics · doi:10.1159/000369993 · Cited by 32
Characteristics of clinical trials in rare vs. common diseases: A register-based Latvian study
Logviss, K., Krievins, D. K., & Purvina, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194494 · Cited by 31
Ehsani‐Moghaddam, B., Queenan, J. A., MacKenzie, J. J., & Birtwhistle, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209018 · Cited by 30
A Computational Framework for Genome-wide Characterization of the Human Disease Landscape
Lee, Y.-S., Krishnan, A., Oughtred, R., Rust, J., Chang, C., Ryu, J., Kristensen, V. N., Dolinski, K. J., Theesfeld, C. L., & Troyanskaya, O. G. (2019) · Cell Systems · doi:10.1016/j.cels.2018.12.010 · Cited by 28
Detecting Acromegaly: Screening for Disease with a Morphable Model
Miller, E. G., Lu, Q., Paisley, A. N., Trainer, P. J., Blanz, V., Dedden, K., & Miller, R. E. (2006) · Lecture notes in computer science · doi:10.1007/11866763_61 · Cited by 28
Industrializing rare disease therapy discovery and development
Ekins, S. (2017) · Nature Biotechnology · doi:10.1038/nbt.3787 · Cited by 28
Design of Biomedical Robots for Phenotype Prediction Problems
deAndrés‐Galiana, E. J., Fernández‐Martínez, J. L., & Sonis, S. T. (2016) · Journal of Computational Biology · doi:10.1089/cmb.2016.0008 · Cited by 27
Adaptive control of epileptiform excitability in an in vitro model of limbic seizures
Panuccio, G., Guez, A., Vincent, R., Avoli, M., & Pineau, J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.002 · Cited by 27
HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis
Lux, A., Müller, R., Tulk, M., Olivieri, C., Zarrabeitia, R., Salonikios, T., & Wirnitzer, B. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-94 · Cited by 26
Rare disease knowledge enrichment through a data-driven approach
Shen, F., Zhao, Y., Wang, L., Rastegar-Mojarad, M., Wang, Y., Liu, S., & Liu, H. (2019) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-019-0752-9 · Cited by 26
From gestalt to gene: early predictive dysmorphic features of PMM2-CDG
Martínez‐Monseny, A. F., Cuadras, D., Bolasell, M., Muchart, J., Arjona, C., Borregán, M., Algrabli, A., Montero, R., Artuch, R., Velázquez-Fragua, R., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105588 · Cited by 25
eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics
Bosio, M., Drechsel, O., Rahman, R., Muyas, F., Rabionet, R., Bezdan, D., Domènech, L., Hor, H., Schott, J., Munell, F., et al. (2019) · Human Mutation · doi:10.1002/humu.23772 · Cited by 24
Browne, C., & Timson, D. J. (2015) · Annals of Human Genetics · doi:10.1111/ahg.12126 · Cited by 23
Deep learning approach for survival prediction for patients with synovial sarcoma
Han, I., Kim, J. H., Park, H., Kim, H., & Seo, S. W. (2018) · Tumor Biology · doi:10.1177/1010428318799264 · Cited by 22
Sensitivity analysis of gene ranking methods in phenotype prediction
deAndrés‐Galiana, E. J., Fernández‐Martínez, J. L., & Sonis, S. T. (2016) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2016.10.012 · Cited by 22
Yang, X., Song, Z., Wu, C., Wang, W., Li, G., Zhang, W., Wu, L., & Lü, K. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2526-2 · Cited by 21
Mears, A. J., Schock, S., Hadwen, J., Putos, S., Dyment, D. A., Boycott, K. M., & MacKenzie, A. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0018-3 · Cited by 20
Orphan drug development: the increasing role of clinical pharmacology
AHMED, M. A., Okour, M., Brundage, R. C., & Kartha, R. V. (2019) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-019-09646-3 · Cited by 20
Detecting Acromegaly: Screening for Disease with a Morphable Model
Miller, E. G., Lu, Q., Paisley, A. N., Trainer, P. J., Blanz, V., Dedden, K., Miller, R. E., Larsen, R., Nielsen, M., & Jon Sporring, A. (2006) · Cited by 17
Inferring characteristic phenotypes via class association rule mining in the bone dysplasia domain
Paul, R., Groza, T., Hunter, J., & Zankl, A. (2013) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2013.12.001 · Cited by 14
Hung, C.-Y., Lin, C., & Lee, C.-C. (2018) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2018.8513479 · Cited by 13
Mücke, U., Klemann, C., Baumann, U., Meyer‐Bahlburg, A., Kortum, X., Klawonn, F., Lechner, W. M., & Grigull, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00384 · Cited by 11
CSAX: Characterizing Systematic Anomalies in eXpression Data
Noto, K., Majidi, S., Edlow, A. G., Wick, H. C., Bianchi, D. W., & Slonim, D. K. (2015) · Journal of Computational Biology · doi:10.1089/cmb.2014.0155 · Cited by 10
Dehiya, V., Thomas, J., & Sael, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204101 · Cited by 6
Application of density estimation algorithms in analyzing co-morbidities of migraine
Yang, M.-H., Yang, F., & Oyang, Y. (2013) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-013-0028-8 · Cited by 5
Important Considerations in the Initial Clinical Evaluation of the Dysmorphic Neonate
Smpokou, P., Lanpher, B. C., & Rosenbaum, K. N. (2015) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000216 · Cited by 2
Cerebrospinal fluid metabolomics in West Syndrome: central role of the serine metabolic pathway
Lagrue, E., Hounoum, B. M., Rullier, C., Andres, C. R., Emond, P., Bocca, C., Castelnau, P., & Blasco, H. (2018) · Journal of Translational Science · doi:10.15761/jts.1000223 · Cited by 1
Research works printed but not linked: 2
- Bishop, C.M. (2006). Pattern Recognition and Machine Learning, Springer. Information Science and Statistics.
- Conejar, 2014, A Medical Decision Support System (DSS) for Ubiquitous Healthcare Diagnosis System, Int. J. Softw. Eng. Its Appl., 8, 8
Cited by
Sorted by citations
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Mannuru, N. R., Shahriar, S., Teel, Z. A., Wang, T., Lund, B. D., Tijani, S., Pohboon, C. O., Agbaji, D. A., Alhassan, J., Galley, J., et al. (2023) · Information Development · doi:10.1177/02666669231200628 · Cited by 426
Drug Repurposing for Rare Diseases
Roessler, H. I., Knoers, N. V. A. M., van Haelst, M. M., & van Haaften, G. W. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.003 · Cited by 290
The use of machine learning in rare diseases: a scoping review
Schaefer, J., Lehne, M., Schepers, J., Prasser, F., & Thun, S. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01424-6 · Cited by 213
Artificial intelligence in rare disease diagnosis and treatment
Wojtara, M. S., Rana, E., Rahman, T., Khanna, P., & Singh, H. (2023) · Clinical and Translational Science · doi:10.1111/cts.13619 · Cited by 174
Metadata
- Authors
- Brasil, S., Pascoal, C., Francisco, R., dos Reis Ferreira, V., A. Videira, P., & Valadão, G.
- Affiliations
- Universidade Nova de Lisboa (PT)
- Portuguese Association for CDG, 2820-381 Lisboa, Portugal
- Universidade Politécnica de Lisboa (PT)
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2019-11-27
- Volume
- 10
- Issue
- 12
- Pages
- 978
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC6947640
- OpenAlex
- W2989824398
- Cited by
- 160
- References
- 102
- Citations by year
- 2026: 17 · 2025: 41 · 2024: 28 · 2023: 22 · 2022: 21 · 2021: 20 · 2020: 11
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/138647/2018, SFRH/BD/124326/2016)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
- Keywords
- artificial intelligence, rare diseases, deep learning, congenital disorders of glycosylation, multi-omics integration, patient registry, drug discovery, diagnosis, clinical trials, translational medicine
- MeSH terms
- Deep Learning, Clinical Trials as Topic, Humans, Rare Diseases, Drug Discovery, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review